WUXI BIOLGCS ADR
- Market cap
- 28.71B
- P/E (TTM)i
- 42.44
- P/Bi
- 4.26
- EPSi
- 0.34
- Div yieldi
- 0.00%
- 52W posi
- 95%
Anonymous reader poll. Unscientific, not investment advice.
WUXI BIOLGCS ADR ended the session at 14.43, down 2.43%. Its market capitalisation is about 28.71B, the #704 most valuable US-listed company we track. The shares sit 95% of the way up their 52-week range of 7.30 to 14.80.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 26% of the universe, above its 200-day average.
- Signal has read BUY for 1 week.
- Its last 4 Buy calls have averaged close to flat (-2%) three months out - no strong edge on this name specifically.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 14.79
- Open
- 14.68
- Day range
- 14.68 - 14.79
- Avg price
- --
- Volume
- 3.66K
- Turnover
- 52.86K
- Turnover ratei
- 0.00%
- Amplitudei
- 0.74%
- 52-week rangei
- 7.30 - 14.80
Valuation
- P/Ei
- --
- P/E (TTM)i
- 42.44
- P/Bi
- 4.26
- EPSi
- 0.34
- Book value / shi
- 3.39
- Net profit
- --
- Net assets
- --
Share structure
- Market cap
- 28.71B
- Float capi
- --
- Shares out
- 1.99B
- Float sharesi
- 1.99B
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
2.5% below the 52-week high
Frequently asked questions
What is the current stock price of WUXI BIOLGCS ADR (WXXWY)?
WUXI BIOLGCS ADR last traded at 14.43. The quote on this page refreshes every few seconds while US markets are open.
What is WUXI BIOLGCS ADR's market cap?
About 28.71B.
What is the P/E ratio of WUXI BIOLGCS ADR?
The trailing twelve-month P/E is 42.44. The Valuation tab shows it against the stock's own five-year range.
Does WUXI BIOLGCS ADR pay a dividend?
WUXI BIOLGCS ADR does not currently pay a regular dividend.
What is WUXI BIOLGCS ADR's StockVane Quant Rating?
The StockVane Momentum strategy currently rates WUXI BIOLGCS ADR a B (Buy). Twelve-month momentum in the top 26% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 19:40:37 · For reference only, not investment advice and not tailored to your situation.